• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DJ1-Nrf2-STING 轴介导了醉茄素 A 在帕金森病中的神经保护作用。

The DJ1-Nrf2-STING axis mediates the neuroprotective effects of Withaferin A in Parkinson's disease.

机构信息

Department of Anatomy, Histology and Embryology, Health Science Center, Peking University, Beijing, China.

Neuroscience Research Institute, Peking University, Beijing, China.

出版信息

Cell Death Differ. 2021 Aug;28(8):2517-2535. doi: 10.1038/s41418-021-00767-2. Epub 2021 Mar 24.

DOI:10.1038/s41418-021-00767-2
PMID:33762743
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8329302/
Abstract

The pathogenesis of Parkinson's disease (PD) remains unclear, and there is no disease-modifying agent for PD. Withaferin A (WA), a naturally occurring compound, has emerged as a neuroprotective agent. However, the mechanisms by which WA is neuroprotective in PD are unknown. Here we show that WA protected against loss of dopaminergic neurons, neuroinflammation, and motor deficits in MPTP-induced PD mouse models. Whole-genome deep sequencing analysis combined with Meta-analysis of human PD studies reveal that DJ1, Nrf2, and STING in substantia nigra pars compacta (SNc) are linked to anti-PD effect of WA. We found that WA activated DJ1 and Nrf2, and suppressed STING within SNc; and overexpression of STING in SNc dampened the effect of WA. Using genetically modified mice (DJ1-KO, Nrf2-KO, STING and STING-KO) and immunolabeling technique, we identified that WA targeted DJ1-Nrf2-STING pathway in dopaminergic neurons; and we demonstrate that STING might be an important factor in PD pathogenesis. In addition, WA alleviated accumulation of phosphorylated α-synuclein (p-α-syn) and insoluble α-syn within SNc in adeno-associated virus (AAV)-mediated human α-syn overexpression PD model. Our comparative analysis on whole-genome transcriptome profiles suggests that STING might be a key target of WA and amantadine in PD treatment. This study highlights a multifaceted role for WA in neuroprotection, and suggests that WA can be a potential candidate for treatment of PD.

摘要

帕金森病(PD)的发病机制尚不清楚,也没有针对 PD 的疾病修饰药物。辣木素 A(WA)是一种天然存在的化合物,已成为一种神经保护剂。然而,WA 在 PD 中具有神经保护作用的机制尚不清楚。在这里,我们表明 WA 可防止 MPTP 诱导的 PD 小鼠模型中多巴胺能神经元的丧失、神经炎症和运动功能障碍。全基因组深度测序分析结合人类 PD 研究的 Meta 分析表明,黑质致密部(SNc)中的 DJ1、Nrf2 和 STING 与 WA 的抗 PD 作用有关。我们发现 WA 激活了 DJ1 和 Nrf2,并抑制了 SNc 中的 STING;而 SNc 中 STING 的过表达削弱了 WA 的作用。使用基因修饰小鼠(DJ1-KO、Nrf2-KO、STING 和 STING-KO)和免疫标记技术,我们确定了 WA 在多巴胺能神经元中靶向 DJ1-Nrf2-STING 通路;并证明 STING 可能是 PD 发病机制中的一个重要因素。此外,WA 减轻了腺相关病毒(AAV)介导的人α-突触核蛋白(α-syn)过表达 PD 模型中 SNc 内磷酸化α-突触核蛋白(p-α-syn)和不溶性α-syn 的积累。我们对全基因组转录组谱的比较分析表明,STING 可能是 WA 和金刚烷胺治疗 PD 的关键靶点。这项研究强调了 WA 在神经保护中的多方面作用,并表明 WA 可能是治疗 PD 的潜在候选药物。

相似文献

1
The DJ1-Nrf2-STING axis mediates the neuroprotective effects of Withaferin A in Parkinson's disease.DJ1-Nrf2-STING 轴介导了醉茄素 A 在帕金森病中的神经保护作用。
Cell Death Differ. 2021 Aug;28(8):2517-2535. doi: 10.1038/s41418-021-00767-2. Epub 2021 Mar 24.
2
The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson's disease.姜黄素通过 Nrf2-NLRP3-caspase-1 轴对帕金森病发挥神经保护作用。
Redox Biol. 2021 Nov;47:102134. doi: 10.1016/j.redox.2021.102134. Epub 2021 Sep 22.
3
Glial Nrf2 signaling mediates the neuroprotection exerted by Blume in Lrrk2-G2019S Parkinson's disease.胶质细胞 Nrf2 信号转导介导 Blume 在 Lrrk2-G2019S 帕金森病中的神经保护作用。
Elife. 2021 Nov 15;10:e73753. doi: 10.7554/eLife.73753.
4
Bruceine D elevates Nrf2 activation to restrain Parkinson's disease in mice through suppressing oxidative stress and inflammatory response.布瑞宁 D 通过抑制氧化应激和炎症反应来提升 Nrf2 激活水平,从而抑制小鼠的帕金森病。
Biochem Biophys Res Commun. 2020 Jun 11;526(4):1013-1020. doi: 10.1016/j.bbrc.2020.03.097. Epub 2020 Apr 19.
5
Neuroprotective effects of protocatechuic aldehyde through PLK2/p-GSK3β/Nrf2 signaling pathway in both and models of Parkinson's disease.原儿茶醛通过PLK2/p-GSK3β/Nrf2信号通路在帕金森病细胞和动物模型中的神经保护作用
Aging (Albany NY). 2019 Nov 6;11(21):9424-9441. doi: 10.18632/aging.102394.
6
Baicalin exerts neuroprotective actions by regulating the Nrf2-NLRP3 axis in toxin-induced models of Parkinson's disease.黄芩通过调节 Nrf2-NLRP3 轴在毒素诱导的帕金森病模型中发挥神经保护作用。
Chem Biol Interact. 2024 Jan 5;387:110820. doi: 10.1016/j.cbi.2023.110820. Epub 2023 Nov 26.
7
The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease.导致帕金森病神经保护作用的Keap1/Nrf2/ARE通路激活背后的主要分子机制。
Neurochem Int. 2022 Jun;156:105325. doi: 10.1016/j.neuint.2022.105325. Epub 2022 Mar 9.
8
Uric acid demonstrates neuroprotective effect on Parkinson's disease mice through Nrf2-ARE signaling pathway.尿酸通过Nrf2-ARE信号通路对帕金森病小鼠表现出神经保护作用。
Biochem Biophys Res Commun. 2017 Dec 2;493(4):1443-1449. doi: 10.1016/j.bbrc.2017.10.004. Epub 2017 Oct 3.
9
Vitamin E Analog Trolox Attenuates MPTP-Induced Parkinson's Disease in Mice, Mitigating Oxidative Stress, Neuroinflammation, and Motor Impairment.维生素 E 类似物 Trolox 可减轻 MPTP 诱导的小鼠帕金森病,减轻氧化应激、神经炎症和运动功能障碍。
Int J Mol Sci. 2023 Jun 9;24(12):9942. doi: 10.3390/ijms24129942.
10
Role of Astrogliosis in the Pathogenesis of Parkinson's Disease: Insights into Astrocytic Nrf2 Pathway as a Potential Therapeutic Target.星形胶质细胞增生在帕金森病发病机制中的作用:星形胶质细胞 Nrf2 通路作为潜在治疗靶点的见解。
CNS Neurol Disord Drug Targets. 2024;23(8):1015-1029. doi: 10.2174/0118715273270473231002104610.

引用本文的文献

1
Transnasal-brain delivery of nanomedicines for neurodegenerative diseases.纳米药物经鼻脑递送用于神经退行性疾病
Front Drug Deliv. 2023 Aug 11;3:1247162. doi: 10.3389/fddev.2023.1247162. eCollection 2023.
2
Modulation of neuronal α1-adrenergic receptor reduces tauopathy and neuroinflammation by inhibiting the STING/NF-κB/NLRP3 signaling pathway in Alzheimer's disease mice.调节神经元α1-肾上腺素能受体可通过抑制阿尔茨海默病小鼠的STING/NF-κB/NLRP3信号通路来减轻tau蛋白病和神经炎症。
J Neuroinflammation. 2025 Jul 17;22(1):187. doi: 10.1186/s12974-025-03506-3.
3
Withaferin A Rescues Brain Network Dysfunction and Cognitive Deficits in a Mouse Model of Alzheimer's Disease.

本文引用的文献

1
Cyclic GMP-AMP synthase promotes the inflammatory and autophagy responses in Huntington disease.环鸟苷酸-腺苷酸合酶促进亨廷顿病中的炎症和自噬反应。
Proc Natl Acad Sci U S A. 2020 Jul 7;117(27):15989-15999. doi: 10.1073/pnas.2002144117. Epub 2020 Jun 24.
2
iPSC modeling of young-onset Parkinson's disease reveals a molecular signature of disease and novel therapeutic candidates.诱导多能干细胞模型在早发性帕金森病中的应用揭示了疾病的分子特征和新的治疗靶点。
Nat Med. 2020 Feb;26(2):289-299. doi: 10.1038/s41591-019-0739-1. Epub 2020 Jan 27.
3
Promising disease-modifying therapies for Parkinson's disease.
Withaferin A可挽救阿尔茨海默病小鼠模型中的脑网络功能障碍和认知缺陷。
Pharmaceuticals (Basel). 2025 May 29;18(6):816. doi: 10.3390/ph18060816.
4
Dingzhen pills inhibit neuronal ferroptosis and neuroinflammation by inhibiting the cGAS-STING pathway for Parkinson's disease mice.丁真丸通过抑制帕金森病小鼠的cGAS-STING途径来抑制神经元铁死亡和神经炎症。
Chin Med. 2025 Jun 16;20(1):87. doi: 10.1186/s13020-025-01135-9.
5
Vimentin network dysregulation mediates neurite deficits in duplication Parkinson's patient-derived midbrain neurons.波形蛋白网络失调介导了帕金森病患者来源的中脑神经元复制中的神经突缺陷。
Sci Adv. 2025 Jun 6;11(23):eadq2742. doi: 10.1126/sciadv.adq2742.
6
Lactobacillus reuteri-derived γ-amino butyric acid alleviates MPTP-induced Parkinson's disease through inhibiting ferroptosis via the AKT-GSK3β-GPX4 axis.罗伊氏乳杆菌衍生的γ-氨基丁酸通过AKT-GSK3β-GPX4轴抑制铁死亡来减轻MPTP诱导的帕金森病。
NPJ Parkinsons Dis. 2025 Jun 4;11(1):149. doi: 10.1038/s41531-025-01022-y.
7
CircPRDM5-mediated regulation of miR-433-3p and HDAC6 in Parkinson's disease: a novel neuroprotective axis.环状PRDM5介导的miR-433-3p和HDAC6在帕金森病中的调控:一种新的神经保护轴
J Transl Med. 2025 May 21;23(1):570. doi: 10.1186/s12967-025-06602-3.
8
Mechanisms and potential therapeutic strategies of withaferin A in breast cancer.Withaferin A在乳腺癌中的作用机制及潜在治疗策略
Pharmacol Rep. 2025 May 20. doi: 10.1007/s43440-025-00736-3.
9
The Discovery of Phages in the Substantia Nigra and Its Implication for Parkinson's Disease.黑质中噬菌体的发现及其对帕金森病的意义。
Research (Wash D C). 2025 Apr 30;8:0657. doi: 10.34133/research.0657. eCollection 2025.
10
The STING Signaling: A Novel Target for Central Nervous System Diseases.STING信号通路:中枢神经系统疾病的新靶点。
Cell Mol Neurobiol. 2025 Apr 7;45(1):33. doi: 10.1007/s10571-025-01550-4.
有前途的帕金森病治疗方法。
Sci Transl Med. 2019 Nov 27;11(520). doi: 10.1126/scitranslmed.aba1659.
4
Aberrant ER Stress Induced Neuronal-IFNβ Elicits White Matter Injury Due to Microglial Activation and T-Cell Infiltration after TBI.内质网应激诱导的神经元-IFNβ异常激活导致创伤性脑损伤后白质损伤,其原因是小胶质细胞激活和 T 细胞浸润。
J Neurosci. 2020 Jan 8;40(2):424-446. doi: 10.1523/JNEUROSCI.0718-19.2019. Epub 2019 Nov 6.
5
A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson's disease.一种野生型葡萄糖脑苷脂酶调节剂改善帕金森病多巴胺能神经元模型中的致病表型。
Sci Transl Med. 2019 Oct 16;11(514). doi: 10.1126/scitranslmed.aau6870.
6
The Nuclear Matrix Protein SAFA Surveils Viral RNA and Facilitates Immunity by Activating Antiviral Enhancers and Super-enhancers.核基质蛋白 SAFA 监测病毒 RNA 并通过激活抗病毒增强子和超级增强子促进免疫。
Cell Host Microbe. 2019 Sep 11;26(3):369-384.e8. doi: 10.1016/j.chom.2019.08.010.
7
The Nrf2 activator RTA-408 attenuates osteoclastogenesis by inhibiting STING dependent NF-κb signaling.Nrf2 激活剂 RTA-408 通过抑制 STING 依赖性 NF-κb 信号通路来抑制破骨细胞分化。
Redox Biol. 2020 Jan;28:101309. doi: 10.1016/j.redox.2019.101309. Epub 2019 Aug 27.
8
and Its Active Principle Scopoletin Mitigate Protein Aggregation and Neuronal Apoptosis through Augmenting the DJ-1/Nrf2/ARE Signaling Pathway.并且它的活性成分东莨菪内酯通过增强 DJ-1/Nrf2/ARE 信号通路来减轻蛋白质聚集和神经元凋亡。
Oxid Med Cell Longev. 2019 May 2;2019:2761041. doi: 10.1155/2019/2761041. eCollection 2019.
9
Association of Antiviral Therapy With Risk of Parkinson Disease in Patients With Chronic Hepatitis C Virus Infection.慢性丙型肝炎病毒感染患者抗病毒治疗与帕金森病风险的关联
JAMA Neurol. 2019 Sep 1;76(9):1019-1027. doi: 10.1001/jamaneurol.2019.1368.
10
Emerging therapies in Parkinson disease - repurposed drugs and new approaches.帕金森病的新兴治疗方法——再利用药物和新方法。
Nat Rev Neurol. 2019 Apr;15(4):204-223. doi: 10.1038/s41582-019-0155-7.